Nasdaq Nordic: Nasdaq Stockholm Welcomes Scandion Oncology to the Nasdaq First North Growth Market
Nasdaq Nordic: Nasdaq Stockholm Welcomes Scandion Oncology to the Nasdaq First North Growth Market Stockholm, February 3, 2020 - Nasdaq (Nasdaq: NDAQ) announces that trading in Scandion Oncology A/S's shares (short name SCOL) commences today on Nasdaq First North Growth Market. The company belongs to the Health care sector. Scandion Oncology is the 4th company to be admitted to trading on Nasdaq's Nordic markets* in 2021. Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have developed resistance to chemotherapy....